| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 02/09/2010 | US7659267 2-(3-cyanophenyl)-4H-1,3-benzothiazin-4-one; cardiovascular, bone or joint diseases, infectious, inflammatory, kidney diseases; safe and good effects of cell death inhibition, Migration Inhibitory Factor (MIF) binding |
| 02/09/2010 | US7659246 Use of cyclic peptide of given structure which is a C5a G protein-coupled receptor inhibitor |
| 02/09/2010 | US7658950 synovial fluids collected, purified and freeze dried for use as replacement fluid in joints; shelf life, sterility; e.g. in horses, synovial fluid from slaughterhouses used in e.g. race horses |
| 02/09/2010 | CA2533906C Chewable capsule and production method thereof |
| 02/09/2010 | CA2484954C 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as vla-4 inhibitors |
| 02/09/2010 | CA2440588C Chronotherapeutic dosage forms |
| 02/09/2010 | CA2413061C Serine protease inhibitors |
| 02/09/2010 | CA2386297C Bicyclic amino acids as pharmaceutical agents |
| 02/09/2010 | CA2286614C Plant extracts for the treatment of increased bone resorption |
| 02/09/2010 | CA2192092C Arylsulfonamido-substituted hydroxamic acids as matrix metalloproteinase inhibitors |
| 02/04/2010 | WO2010014839A1 Betalain compositions and uses thereof |
| 02/04/2010 | WO2010013975A2 A pharmaceutical composition for preventing or treating osteoporosis comprising benzamidine derivative or its salt, and bisphosphonate |
| 02/04/2010 | WO2010013595A1 (5-membered)-(5-membered) or (5-membered)-(6-membered) fused ring cycloalkylamine derivative |
| 02/04/2010 | WO2010013498A1 Therapeutic agent or preventive agent for osteoarthritis |
| 02/04/2010 | WO2010013494A1 Pharmaceutical composition comprising botulinum neurotoxin preparation incapable of being synaptically transported, and use thereof |
| 02/04/2010 | WO2010013143A2 Methods for inhibiting mast cell activation and treating mast cell-dependent inflammatory diseases and disorders using lactobacillus |
| 02/04/2010 | WO2010013086A1 Phosphorylated dendrimers as antiinflammatory drugs |
| 02/04/2010 | WO2010012964A2 Thiophene-2-carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 02/04/2010 | WO2010012399A1 Indolylamides as modulators of the ep<sb>2</sb> receptor |
| 02/04/2010 | WO2010012025A1 Amnion epithelial cells for the treatment of degenerative disc disease |
| 02/04/2010 | WO2009001129A9 1-cyanocyclopropyl-derivatives as cathepsin k inhibitors |
| 02/04/2010 | US20100029782 Calcilytic Compounds |
| 02/04/2010 | US20100029766 Blends Comprising a Substituted Fatty Acid or a Derivative Thereof |
| 02/04/2010 | US20100029758 Derivatives of isoflavones |
| 02/04/2010 | US20100029728 Phosphodiesterase inhibitors |
| 02/04/2010 | US20100029719 Arylsulfonamide derivatives as c-jun-n-terminal kinases (jnk's) inhibitors |
| 02/04/2010 | US20100029709 Novel compounds useful for the treatment of degenerative and inflammatory diseases |
| 02/04/2010 | US20100029675 Pyrimidine-2, 4-diamine JAK2 Kinase inhibiting anti-inflammation use |
| 02/04/2010 | US20100029645 Inhibitors of Cytosolic Phospholipase A2 |
| 02/04/2010 | US20100029631 Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient |
| 02/04/2010 | US20100029603 16alpha-methyl or ethyl substituted estrogens |
| 02/04/2010 | US20100029599 Indolylamides as modulators of the EP2 receptor |
| 02/04/2010 | US20100029596 Method of treating or preventing osteoporosis comprising administering to a patient in need thereof an effective amount of pharmacuetical composition comprising benzamidine derivative or it's salt, and bisphosphonate |
| 02/04/2010 | US20100029595 Method of treating or preventing osteoporosis comprising administering to a patient in need thereof an effective amount of pharmaceutical composition comprising benzamidine derivatives or their salts, and alendronic acid or its salt |
| 02/04/2010 | US20100029567 Method of correcting imbalance between bone resorption and bone formation and kits and compositions therefor |
| 02/04/2010 | US20100029564 Novel process of solubilizing protein from a proteinaceous material and compositions thereof |
| 02/04/2010 | US20100029562 hG31P Expression System |
| 02/04/2010 | US20100029556 Stable composition comprising a bone anabolic protein, namely a pthrp analogue, and uses thereof |
| 02/04/2010 | US20100029549 Situ self-setting mineral-polymer hybrid materials, composition and use thereof |
| 02/04/2010 | US20100028455 Nutritional supplement |
| 02/04/2010 | US20100028445 Polymer |
| 02/04/2010 | US20100028430 Material and manufacturing method of bioactive protein-calcium phosphate composite |
| 02/04/2010 | US20100028426 Time-specific delayed/pulsatile release dosage forms. |
| 02/04/2010 | US20100028367 Sgp130/fc dimers |
| 02/04/2010 | US20100028349 activates FGF receptors, regulates the growth and differentiation of cells within the liver, regulates other cell types following secretion from the liver, plays a role in liver chemotaxis, has an oncogenic activity, or serves as an antigen for generating antibodies; treating diabetes or obesity |
| 02/04/2010 | US20100028345 Il-17 receptor a antigen binding proteins |
| 02/04/2010 | US20100028343 for treating degenerative cartilaginous disorders and other inflammatory diseases; interleukin-17 receptor protein |
| 02/04/2010 | US20100028335 Compositions and Methods to Treat Bone Related Disorders |
| 02/04/2010 | US20100028308 Methods to maintain, improve and restore the cartilage phenotype of chondrocytes |
| 02/04/2010 | US20100028262 3,4-methylenedioxy-substituted chalcones as therapeutic agents |
| 02/04/2010 | DE20321786U1 Kombinationspräparat aus oralem Kontrazeptivum und Calcium/Vitamin D Combination preparation of oral contraceptive and calcium / vitamin D |
| 02/04/2010 | CA2732864A1 A pharmaceutical composition for preventing or treating osteoporosis comprising benzamidine derivative or its salt, and bisphosphonate |
| 02/04/2010 | CA2732715A1 Treatment agent or preventative agent for osteoarthritis |
| 02/04/2010 | CA2731358A1 5/5-or 5/6-membered condensed ring cycloalkylamine derivative |
| 02/03/2010 | EP2149378A1 Topical formulations for the symptomatic treatment of musculoskeletal disorders |
| 02/03/2010 | EP2148708A1 Composition for enhancing bone formation |
| 02/03/2010 | EP2148691A2 Local complement inhibition for treatment of complement-mediated disorders |
| 02/03/2010 | EP1511742B1 Kinase inhibitors |
| 02/03/2010 | CN100586464C Plaster of easing pain, removing swelling, promoting blood flow and removing blood stasis, activating the channels and removing rheumatism and preparation method |
| 02/02/2010 | US7655780 Integrin-linked kinase and its uses |
| 02/02/2010 | US7655760 Antibodies to the polypeptide hormone phosphatonin |
| 02/02/2010 | US7655688 Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 02/02/2010 | US7655663 (2S)-4,4-difluoro-1-(2-{[1-(2-pyrazinyl)piperidin-4-yl]amino}acetyl)-2-pyrrolidine carbonitrile; enzyme inhibitors; diabetes |
| 02/02/2010 | US7655651 Biphenyl-4-carboxylic acid (4-chloro-3-{7-[4-(2-diethylamino-ethoxy)-phenylamino]-1-methyl-2-oxo-1,4-dihydro-2H-pyrimido[4,5-d]pyrimidin-3-yl}-phenyl)-amide; protein kinase inhibitors |
| 02/02/2010 | US7655633 Beta-D-Glucopyranosyloxy)-3-(3-fluoro-4-methylbenzyl)-4,6-dimethylpyridine; sodium glucose co-transporter 2 (SGLT2) inhibitors; excellent hypoglycemic effect by excreting excess glucose into the urine through preventing the reabsorption of glucose at the kidney; antidiabetic agents; hyperglycemia |
| 02/02/2010 | US7655632 prevention or treatment of disease associated with hyperglycemia: diabetes, impaired glucose tolerance, impaired fasting glycemia, diabetic complications or obesity; e.g. 4-[(4-{3-[1-carbamoyl-1-(methyl)-ethylcarbamoyl]propyl}-2-methylphenyl)methyl]-3-( beta -D-glucopyranosyloxy)-5-isopropyl-1H-pyrazole |
| 02/02/2010 | US7655628 Method for treating liver cirrhosis or interstitial pulmonary fibrosis |
| 02/02/2010 | US7655624 Peptide and peptide mimetic conjugates with integrin-inhibitor properties |
| 02/02/2010 | US7655420 Identifying sclerostin antagonist via abilty to prevent apoptosis; treating osteoporosis |
| 02/02/2010 | US7655261 Medicament and method of treatment of patients with heavy metals |
| 02/02/2010 | CA2485685C Calcium receptor modulating agents |
| 02/02/2010 | CA2477756C Modified phosphocalcic compound, injectable composition containing same |
| 02/02/2010 | CA2396158C Dipeptide nitrile cathepsin k inhibitors |
| 02/02/2010 | CA2357459C Method for improving bone mineralization |
| 01/28/2010 | WO2010011879A2 Methods and compositions for treating and preventing autoimmune diseases |
| 01/28/2010 | WO2010011857A2 Parenteral administration of a glucosamine |
| 01/28/2010 | WO2010011599A2 Pimethixene derivatives for promoting bone growth |
| 01/28/2010 | WO2010011591A1 Method of treating inflammation disorders using extracts of passion fruit |
| 01/28/2010 | WO2010011349A2 Pyrimidine-2,4-diamine jak2 kinase inhibiting anti-inflammation use |
| 01/28/2010 | WO2010011314A1 Cyclic inhibitors of 11 beta-hydroxysteroid dehydrogenase 1 |
| 01/28/2010 | WO2010010288A2 Alkylthiazol carbamate derivatives, preparation thereof and therapeutic use thereof |
| 01/28/2010 | WO2010010191A1 Novel compounds useful for the treatment of degenerative and inflammatory diseases. |
| 01/28/2010 | WO2010010190A1 Novel compounds useful for the treatment of degenerative and inflammatory diseases |
| 01/28/2010 | WO2010010189A1 Novel compounds useful for the treatment of degenerative and inflammatory diseases |
| 01/28/2010 | WO2010010188A1 Novel compounds useful for the treatment of degenerative and inflammatory diseases. |
| 01/28/2010 | WO2010010187A1 Novel compounds useful for the treatment of degenerative and inflammatory diseases |
| 01/28/2010 | WO2010010186A1 Novel compounds useful for the treatment of degenerative and inflammatory diseases |
| 01/28/2010 | WO2010010184A1 [1, 2, 4] triazolo [1, 5-a] pyridines as jak inhibitors |
| 01/28/2010 | WO2009134856A3 Pharmaceutical gallium compounds, composition and methods of preparation |
| 01/28/2010 | WO2009129148A3 Methods and compositions for treating intervertebral disc herniations |
| 01/28/2010 | WO2009128076A3 Methods of generating and using procollagen |
| 01/28/2010 | WO2008137816A8 Tricyclic compounds as matrix metalloproteinase inhibitors |
| 01/28/2010 | US20100022783 Cyclohexanecarboxylic acid compound |
| 01/28/2010 | US20100022611 1,5-Diaryl-Pyrazoles As Cannabinoid Receptor Neutral Antagonists Useful As Therapeutic Agents |
| 01/28/2010 | US20100022601 Sulfonamide compounds and the use |
| 01/28/2010 | US20100022550 Tetrahydrocarbazole derivatives useful as androgen receptor modulators |
| 01/28/2010 | US20100022536 Inhibitors of Cytosolic Phospholipase A2 |
| 01/28/2010 | US20100022481 Drug Carriers, Their Synthesis, and Methods of Use Thereof |
| 01/28/2010 | US20100022480 Solid Oral Dosage Form Containing An Enhancer |
| 01/28/2010 | US20100021544 Hydrogel and biomedical applications thereof |